Woo Ho Kim spends much of his time researching Cancer, Internal medicine, Pathology, Cancer research and Oncology. Woo Ho Kim has researched Cancer in several fields, including Survival analysis and Lymph. His studies deal with areas such as Gastroenterology and Surgery as well as Internal medicine.
His Pathology study combines topics from a wide range of disciplines, such as Stomach neoplasm, Microsatellite instability and Gene expression profiling. His Cancer research research integrates issues from Protein kinase B, Endocrinology, Carcinogenesis, Tumor suppressor gene and CpG site. His work deals with themes such as Retrospective cohort study, Clinical endpoint, Metastasis, Hazard ratio and Colorectal cancer, which intersect with Oncology.
Cancer, Pathology, Cancer research, Internal medicine and Immunohistochemistry are his primary areas of study. As part of one scientific family, Woo Ho Kim deals mainly with the area of Cancer, narrowing it down to issues related to the Molecular biology, and often Gene and Cell culture. Lymph node is closely connected to Metastasis in his research, which is encompassed under the umbrella topic of Pathology.
His research in Cancer research intersects with topics in DNA methylation, Cancer cell, Apoptosis, Carcinogenesis and Microsatellite instability. The various areas that Woo Ho Kim examines in his Internal medicine study include Gastroenterology and Oncology. His Immunohistochemistry research is multidisciplinary, relying on both In situ hybridization and Clinical significance.
His scientific interests lie mostly in Cancer, Cancer research, Internal medicine, Immunohistochemistry and Oncology. His Cancer research incorporates elements of Chemotherapy, In situ hybridization and Pathology. His research integrates issues of Cancer cell, Carcinogenesis, Microsatellite instability, Colorectal cancer and Epigenetics in his study of Cancer research.
As a part of the same scientific family, he mostly works in the field of Internal medicine, focusing on Gastroenterology and, on occasion, Early Gastric Cancer, Odds ratio and Adenoma. His study on Immunohistochemistry also encompasses disciplines like
Woo Ho Kim mainly investigates Cancer, Cancer research, Internal medicine, Oncology and Microsatellite instability. His Cancer research incorporates themes from In situ hybridization and Pathology. His Pathology study frequently draws connections between related disciplines such as Colorectal cancer.
His Cancer research study combines topics in areas such as Epithelial–mesenchymal transition, Wnt signaling pathway, Methylation, Cancer cell and Epigenetics. His work in the fields of Internal medicine, such as Cohort, Univariate analysis, Hazard ratio and Retrospective cohort study, intersects with other areas such as In patient. His Microsatellite instability study integrates concerns from other disciplines, such as Immunohistochemistry, Stage ii, PD-L1 and Apoptosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma
Gyeong Hoon Kang;Sun Lee;Woo Ho Kim;Hye Won Lee.
American Journal of Pathology (2002)
Promoter methylation and silencing of PTEN in gastric carcinoma.
Young-Hwa Kang;Hye Seung Lee;Woo Ho Kim.
Laboratory Investigation (2002)
Nomogram Predicting Long-Term Survival After D2 Gastrectomy for Gastric Cancer
Dong Seok Han;Yun Suhk Suh;Seong Ho Kong;Hyuk Joon Lee.
Journal of Clinical Oncology (2012)
Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer
Yung Jue Bang;Seock Ah Im;Keun Wook Lee;Jae Yong Cho.
Journal of Clinical Oncology (2015)
Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.
Hye Seong Ahn;Hyuk Joon Lee;Seokyung Hahn;Woo Ho Kim.
Systemic Gene Therapy with p53 Reduces Growth and Metastases of a Malignant Human Breast Cancer in Nude Mice
Leslie A. Lesoon-Wood;Woo Ho Kim;Hynda K. Kleinman;Bruce D. Weintraub.
Human Gene Therapy (1995)
Expression of mucins and cytokeratins in primary carcinomas of the digestive system
Min Jong Lee;Hye Seung Lee;Woo Ho Kim;Yunhee Choi.
Modern Pathology (2003)
Phase II study and biomarker analysis of cetuximab combined with modified FOLFOX6 in advanced gastric cancer.
Sae-Won Han;Sae-Won Han;Do-Youn Oh;Do-Youn Oh;Seock-Ah Im;Seock-Ah Im;S. R. Park.
British Journal of Cancer (2009)
Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines
Dong Kyun Woo;Hee Sung Kim;Hye Seung Lee;Young Hwa Kang.
International Journal of Cancer (2001)
Aberrant CpG island methylation of multiple genes in intrahepatic cholangiocarcinoma.
Sun Lee;Woo Ho Kim;Hwoon Yong Jung;Moon Ho Yang.
American Journal of Pathology (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: